⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 16, 2024PLoS ONEOpen Access

Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial

Ashenafi S. Cherkos Sylvia M. LaCourse Daniel A. Enquobahrie Jaclyn N Escudero Jerphason Mecha Daniel Matemo John Kinuthia Sarah Iribarren Grace John‐Stewart

View Full Paper

Ask AI

Bookmark

Share

Abstract

Isoniazid preventive therapy (IPT) decreases risk of tuberculosis (TB) disease; impact on long-term infant growth is unknown. In a recent randomized trial (RCT), we assessed IPT effects on infant growth without known TB exposure.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cherkos et al. (2024) studied this question.

synapsesocial.com/papers/68e5bf9fb6db643587556f70 https://doi.org/10.1371/journal.pone.0293708

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Impact of Isoniazid Preventive Therapy on Tuberculosis Infection and Disease Progression.Cohort Study · 2026
2Outcomes of isoniazid preventive therapy in pregnant women living with HIV: A systematic review and meta-analysisMeta-Analysis · 2026
3Isoniazid monotherapy for tuberculosis prevention during pregnancy and adverse outcomes in women living with HIV in Uganda: A propensity score–weighted analysis of routine care dataCohort Study · 2026
4Isoniazid Tuberculosis Preventive Therapy in HIV-Infected Adults Accessing Antiretroviral Therapy: A Botswana Experience, 2004-2006Clinical Trial · 2010 · 49 citations
5The effect of antenatal isoniazid preventive therapy on birth outcomes in Western KenyaRetrospective Study · 2023 · 1 citations